Moreover, several studies consistently found no association between TGFα mRNA expression and clinical outcome of cetuximab-based therapies in colorectal cancer patients (Baker et al. 2011; Cushman et al. 2015; Khambata-Ford et al. 2007; Pentheroudakis et al. 2013). The gene discussed is TGFA; the disease is colorectal cancer.